Joel Greenblatt | Gotham Asset Management, Llc

Fund Stats for Q4 2016Joel Greenblatt is the managing partner of Gotham Asset Management, Llc. The 13F filing for 2016 Q4 included $7.77B in managed 13F securities and a top 10 holdings concentration of 8.88%. Gotham Asset Management, Llc's largest holding is CVS Health Corporation with shares held of 1.06M. 10kreader has 37 13F filings available for Gotham Asset Management, Llc.Joel Greenblatt is the managing partner of Gotham Asset Management, Llc. The 13F filing for 2016 Q4 included $7.77B in managed 13F securities and a top 10 holdings concentration of 8.88%. Gotham Asset...

About Joel GreenblattKnown for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC), Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He is the author of two investment books, including 'The Little Book that Beats the Market.' He is also an Adjunct Professor with Columbia Business School.Greenblatt tries to find cheap and good companies. He looks for value with a catalyst, so nice things happen sooner. Greenblatt likes special situations, and thinks that they are simply different places to find cheap stocks. In his own hedge fund, Greenblatt uses the basic principals in the Magic Formula: Look for high ROC and high earnings yield. He tries to figure out what 'normalized earnings' will be 3-4 years into the future. Greenblatt makes sure the stock is very cheap based on normalized earnings.source: gurufocus.comKnown for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC), Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He i...

Go to:

Company	Ticker	Market Value	% Portfolio	Shares	Change	Chg. Shares	Quarter End Price	Current Price	Yearly High	Yearly Low	Market Cap	% Owned
CVS Health Corporation	CVS	83.32M	1.07%	1.06M	139.61%	615.18K	$78.91	$102.31	$111.25	$81.78	134.32B	0.08%
Cisco Systems, Inc.	CSCO	75.30M	0.97%	2.49M	13.00%	286.68K	$30.22	$43.29	$64.29	$40.82	177.87B	0.06%
The Boeing Company	BA	74.53M	0.96%	478.73K	60.19%	179.88K	$155.68	$149.78	$233.94	$113.02	88.94B	0.08%
Gilead Sciences, Inc.	GILD	73.42M	0.95%	1.03M	11.01%	101.67K	$71.61	$65.00	$74.12	$57.17	81.47B	0.08%
QUALCOMM Incorporated	QCOM	72.56M	0.93%	1.11M	4.04%	43.22K	$65.20	$124.98	$193.58	$118.23	140.35B	0.10%
Express Scripts Hldg Co		70.87M	0.91%	1.03M	18.19%	158.53K	$68.79
Biogen Inc.	BIIB	68.15M	0.88%	240.31K	-2.10%	-5.16K	$283.58	$206.72	$304.21	$187.16	30.00B	0.17%
AbbVie Inc.	ABBV	58.58M	0.75%	935.44K	36.69%	251.08K	$62.62	$142.51	$175.91	$105.56	246.74B	0.05%
Walgreens Boots Alliance, Inc.	WBA	56.93M	0.73%	687.94K	-17.29%	-143.84K	$82.76	$34.23	$55	$33.95	29.58B	0.08%
Baxter International Inc.	BAX	56.40M	0.73%	1.27M	99.33%	633.82K	$44.34	$58.97	$89.7	$54.45	29.70B	0.25%
Delta Air Lines, Inc.	DAL	55.93M	0.72%	1.14M	-32.76%	-553.93K	$49.19	$33.28	$46.27	$28.1	21.34B	0.18%
Ingersoll Rand Inc.	IR	55.77M	0.72%	743.15K	New	743.15K	$75.04	$49.31	$62.64	$39.285	19.88B	0.18%
Priceline Grp Inc		55.59M	0.72%	37.92K	474.40%	31.32K	$1,466.06
Emerson Electric Co.	EMR	55.09M	0.71%	988.12K	-9.19%	-99.96K	$55.75	$80.52	$100.47	$76.16	47.61B	0.17%
Johnson & Johnson	JNJ	54.81M	0.71%	475.72K	122.26%	261.68K	$115.21	$165.08	$186.69	$155.72	434.03B	0.02%
Target Corporation	TGT	54.63M	0.70%	756.30K	13.65%	90.81K	$72.23	$165.01	$268.98	$137.16	75.95B	0.16%
Twenty First Centy Fox Inc		50.96M	0.66%	1.82M	-28.27%	-716.43K	$28.04
Verizon Communications Inc.	VZ	50.59M	0.65%	947.66K	-30.82%	-422.10K	$53.38	$41.03	$55.51	$40.705	172.31B	0.02%
Tyson Foods, Inc.	TSN	49.90M	0.64%	808.98K	107.50%	419.10K	$61.68	$72.10	$100.72	$71.68	25.93B	0.22%
Applied Materials, Inc.	AMAT	46.81M	0.60%	1.45M	-4.35%	-65.94K	$32.27	$88.92	$167.06	$82.67	76.50B	0.17%

Holdings Breakdown

Disclaimer: Investor holdings are derived from 13F filings which are required to be filed by all institutional investment managers with at least $100 million in assets under management. Limitations to this data include but are not limited to: (1) SEC does not review 13Fs for accuracy or completeness, (2) cash, foreign stocks, short positions, and a variety of other assets are not required to be reported, (3) 13Fs are often filed 45 days after the end of the quarter, by which time a manager's positions and outlook could have changed significantly, (4) the market value does not tell us at what price the manager acquired the asset, and (5) data is only available starting mid 2013. Please do your own research before drawing any conclusions from this data.